866-997-4948(US-Canada Toll Free)

China Breast Cancer Therapeutics Drugs Market Research Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Cancer

No. of Pages : 120 Pages

Notes:
Sales, means the sales volume of Breast Cancer Therapeutics Drugs
Revenue, means the sales value of Breast Cancer Therapeutics Drugs

This report studies Breast Cancer Therapeutics Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
Bayer HealthCare
Eli Lily
Pfizer
Novartis
Eisai
Halozyme Therapeutics
Roche
Puma Biotechnology
Janssen Biotech
AbbVie
BioMarin
Array BioPharma
Merck
Syndax
MacroGenics

Market Segment by Regions (provinces), covering
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China
Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
Mitotic Inhibitors
Anti-metabolites
Zoladex
Aromatase Inhibitors
HER2 Inhibitors
Split by Application, this report focuses on consumption, market share and growth rate of Breast Cancer Therapeutics Drugs in each application, can be divided into
Hospital
Medical Research Laboratory
Others

Table of Contents

China Breast Cancer Therapeutics Drugs Market Research Report 2017
1 Breast Cancer Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Breast Cancer Therapeutics Drugs
1.2 Breast Cancer Therapeutics Drugs Segment by Type
1.2.1 China Production Market Share of Breast Cancer Therapeutics Drugs Type in 2015
1.2.2 Mitotic Inhibitors
1.2.3 Anti-metabolites
1.2.4 Zoladex
1.2.5 Aromatase Inhibitors
1.2.6 HER2 Inhibitors
1.3 Applications of Breast Cancer Therapeutics Drugs
1.3.1 Breast Cancer Therapeutics Drugs Consumption Market Share by Application in 2015
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 China Market Size (Value) of Breast Cancer Therapeutics Drugs (2012-2022)
1.5 China Breast Cancer Therapeutics Drugs Status and Outlook
1.6 Government Policies

2 China Breast Cancer Therapeutics Drugs Market Competition by Manufacturers
2.1 China Breast Cancer Therapeutics Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Breast Cancer Therapeutics Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Breast Cancer Therapeutics Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Breast Cancer Therapeutics Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Breast Cancer Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Breast Cancer Therapeutics Drugs Market Concentration Rate
2.5.2 Breast Cancer Therapeutics Drugs Market Share of Top 3 and Top 5 Manufacturers

3 China Breast Cancer Therapeutics Drugs Manufacturers Profiles/Analysis
3.1 Bayer HealthCare
3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.1.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.1.2.1 Mitotic Inhibitors
3.1.2.2 Anti-metabolites
3.1.3 Bayer HealthCare Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.1.4 Main Business/Business Overview
3.2 Eli Lily
3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.2.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.2.2.1 Mitotic Inhibitors
3.2.2.2 Anti-metabolites
3.2.3 Eli Lily 120 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.2.4 Main Business/Business Overview
3.3 Pfizer
3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.3.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.3.2.1 Mitotic Inhibitors
3.3.2.2 Anti-metabolites
3.3.3 Pfizer 127 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.3.4 Main Business/Business Overview
3.4 Novartis
3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.4.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.4.2.1 Mitotic Inhibitors
3.4.2.2 Anti-metabolites
3.4.3 Novartis Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.4.4 Main Business/Business Overview
3.5 Eisai
3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.5.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.5.2.1 Mitotic Inhibitors
3.5.2.2 Anti-metabolites
3.5.3 Eisai Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.5.4 Main Business/Business Overview
3.6 Halozyme Therapeutics
3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.6.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.6.2.1 Mitotic Inhibitors
3.6.2.2 Anti-metabolites
3.6.3 Halozyme Therapeutics Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.6.4 Main Business/Business Overview
3.7 Roche
3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.7.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.7.2.1 Mitotic Inhibitors
3.7.2.2 Anti-metabolites
3.7.3 Roche Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.7.4 Main Business/Business Overview
3.8 Puma Biotechnology
3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.8.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.8.2.1 Mitotic Inhibitors
3.8.2.2 Anti-metabolites
3.8.3 Puma Biotechnology Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.8.4 Main Business/Business Overview
3.9 Janssen Biotech
3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.9.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.9.2.1 Mitotic Inhibitors
3.9.2.2 Anti-metabolites
3.9.3 Janssen Biotech Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.9.4 Main Business/Business Overview
3.10 AbbVie
3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
3.10.2 Breast Cancer Therapeutics Drugs Product Type, Application and Specification
3.10.2.1 Mitotic Inhibitors
3.10.2.2 Anti-metabolites
3.10.3 AbbVie Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
3.10.4 Main Business/Business Overview
3.11 BioMarin
3.12 Array BioPharma
3.13 Merck
3.14 Syndax
3.15 MacroGenics

4 China Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Consumption, Export and Import (2012-2017)
4.1 China Breast Cancer Therapeutics Drugs Capacity, Production and Growth (2012-2017)
4.2 China Breast Cancer Therapeutics Drugs Revenue and Growth (2012-2017)
4.3 China Breast Cancer Therapeutics Drugs Production, Consumption, Export and Import (2012-2017)

5 China Breast Cancer Therapeutics Drugs Production, Revenue (Value), Price Trend by Type
5.1 China Breast Cancer Therapeutics Drugs Production and Market Share by Type (2012-2017)
5.2 China Breast Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)
5.3 China Breast Cancer Therapeutics Drugs Price by Type (2012-2017)
5.4 China Breast Cancer Therapeutics Drugs Production Growth by Type (2012-2017)

6 China Breast Cancer Therapeutics Drugs Market Analysis by Application
6.1 China Breast Cancer Therapeutics Drugs Consumption and Market Share by Application (2012-2017)
6.2 China Breast Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Application
6.3.2 Emerging Markets/Countries

7 ChinaBreast Cancer Therapeutics Drugs Market Analysis by Regions (Provinces)
7.1 China Breast Cancer Therapeutics Drugs Production, Production Value and Price by Regions (Provinces)(2012-2017)
7.1.1 China Breast Cancer Therapeutics Drugs Production and Market Share by Regions (Provinces)(2012-2017)
7.1.2 China Breast Cancer Therapeutics Drugs Production Value and Market Share by Regions (Provinces)(2012-2017)
7.1.3 China Breast Cancer Therapeutics Drugs Sales Price by Regions (Provinces)(2012-2017)
7.2 China Breast Cancer Therapeutics Drugs Consumption by Regions (Provinces)(2012-2017)
7.3 China Breast Cancer Therapeutics Drugs Production, Consumption, Export and Import (2012-2017)

8 Breast Cancer Therapeutics Drugs Manufacturing Cost Analysis
8.1 Breast Cancer Therapeutics Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Breast Cancer Therapeutics Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Breast Cancer Therapeutics Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 China Breast Cancer Therapeutics Drugs Market Forecast (2017-2022)
12.1 China Breast Cancer Therapeutics Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.2 China Breast Cancer Therapeutics Drugs Production, Import, Export and Consumption Forecast (2017-2022)
12.3 China Breast Cancer Therapeutics Drugs Production Forecast by Type (2017-2022)
12.4 China Breast Cancer Therapeutics Drugs Consumption Forecast by Application (2017-2022)
12.5 China Breast Cancer Therapeutics Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.5.1 China Breast Cancer Therapeutics Drugs Production Forecast by Regions (Provinces)(2017-2022)
12.5.2 China Breast Cancer Therapeutics Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
12.5.3 China Breast Cancer Therapeutics Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)
12.6 Breast Cancer Therapeutics Drugs Price Forecast (2017-2022)

13 Research Findings and Conclusion

14 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Breast Cancer Therapeutics Drugs
Figure China Production Market Share of Breast Cancer Therapeutics Drugs by Type in 2015
Figure Product Picture of Mitotic Inhibitors
Table Major Manufacturers of Mitotic Inhibitors
Figure Product Picture of Anti-metabolites
Table Major Manufacturers of Anti-metabolites
Figure Product Picture of Zoladex
Table Major Manufacturers of Zoladex
Figure Product Picture of Aromatase Inhibitors
Table Major Manufacturers of Aromatase Inhibitors
Figure Product Picture of HER2 Inhibitors
Table Major Manufacturers of HER2 Inhibitors
Table Breast Cancer Therapeutics Drugs Consumption Market Share by Application in 2015
Figure Hospital Examples
Figure Medical Research Laboratory Examples
Figure Others Examples
Figure China Breast Cancer Therapeutics Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Table China Breast Cancer Therapeutics Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Breast Cancer Therapeutics Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Breast Cancer Therapeutics Drugs Capacity of Key Manufacturers in 2015
Figure China Breast Cancer Therapeutics Drugs Capacity of Key Manufacturers in 2016
Table China Breast Cancer Therapeutics Drugs Production of Key Manufacturers (2015 and 2016)
Table China Breast Cancer Therapeutics Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Breast Cancer Therapeutics Drugs Production Share by Manufacturers
Figure 2016 Breast Cancer Therapeutics Drugs Production Share by Manufacturers
Table China Breast Cancer Therapeutics Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table 2016 China Breast Cancer Therapeutics Drugs Revenue Share by Manufacturers
Table China Market Breast Cancer Therapeutics Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Breast Cancer Therapeutics Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Breast Cancer Therapeutics Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Breast Cancer Therapeutics Drugs Product Type
Figure Breast Cancer Therapeutics Drugs Market Share of Top 3 Manufacturers
Figure Breast Cancer Therapeutics Drugs Market Share of Top 5 Manufacturers
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Eli Lily Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lily Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lily Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Halozyme Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Halozyme Therapeutics Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Halozyme Therapeutics Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Puma Biotechnology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Puma Biotechnology Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Puma Biotechnology Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table Janssen Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Biotech Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Biotech Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Breast Cancer Therapeutics Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Breast Cancer Therapeutics Drugs Market Share (2012-2017)
Table BioMarin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Array BioPharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Syndax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MacroGenics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Figure China Breast Cancer Therapeutics Drugs Capacity, Production and Growth (2012-2017)
Figure China Breast Cancer Therapeutics Drugs Revenue (Million USD) and Growth (2012-2017)
Table China Breast Cancer Therapeutics Drugs Production, Consumption, Export and Import (2012-2017)
Table China Breast Cancer Therapeutics Drugs Production by Type (2012-2017)
Table China Breast Cancer Therapeutics Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Breast Cancer Therapeutics Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Breast Cancer Therapeutics Drugs by Type
Table China Breast Cancer Therapeutics Drugs Revenue by Type (2012-2017)
Table China Breast Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Breast Cancer Therapeutics Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Breast Cancer Therapeutics Drugs by Type
Table China Breast Cancer Therapeutics Drugs Price by Type (2012-2017)
Figure China Breast Cancer Therapeutics Drugs Production Growth by Type (2012-2017)
Table China Breast Cancer Therapeutics Drugs Consumption by Application (2012-2017)
Table China Breast Cancer Therapeutics Drugs Consumption Market Share by Application (2012-2017)
Figure China Breast Cancer Therapeutics Drugs Consumption Market Share by Application in 2015
Table China Breast Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
Figure China Breast Cancer Therapeutics Drugs Consumption Growth Rate by Application (2012-2017)
Table China Breast Cancer Therapeutics Drugs Production by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Production Market Share by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Production Value by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Production Value Market Share by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Sales Price by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Consumption by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Consumption Market Share by Regions (Provinces)(2012-2017)
Table China Breast Cancer Therapeutics Drugs Production, Consumption, Export and Import (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Breast Cancer Therapeutics Drugs
Figure Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs
Figure Breast Cancer Therapeutics Drugs Industrial Chain Analysis
Table Raw Materials Sources of Breast Cancer Therapeutics Drugs Major Manufacturers in 2015
Table Major Buyers of Breast Cancer Therapeutics Drugs
Table Distributors/Traders List
Figure China Breast Cancer Therapeutics Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
Figure China Breast Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)
Table China Breast Cancer Therapeutics Drugs Production, Import, Export and Consumption Forecast (2017-2022)
Table China Breast Cancer Therapeutics Drugs Production Forecast by Type (2017-2022)
Table China Breast Cancer Therapeutics Drugs Consumption Forecast by Application (2017-2022)
Table China Breast Cancer Therapeutics Drugs Production Forecast by Regions (Provinces)(2017-2022)
Table China Breast Cancer Therapeutics Drugs Consumption Forecast by Regions (Provinces)(2017-2022)
Table China Breast Cancer Therapeutics Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *